Committed to research and improving lives

Clinical Research

Profound Medical is committed to research, innovation, improving procedure efficiency and saving lives. We are dedicated to changing the standard of care through quality clinical evidence, working in close partnership with clinicians, physicians, hospitals, and professional associations.

Featured Presentations

Prostate Cancer Ablation Using MRI-Guided Transurethral Ultrasound (TULSA-PRO): How I Do it?

Ram A. Pathak, MD

Klotz et al, Focal Therapy Society Annual Meeting 2023

Featured Publications

Pivotal trial of MRI-guided transurethral ultrasound ablation (TULSA) of localized prostate cancer: 4-year follow-up
Pavlovich et al, AUA 2023 Annual Meeting (abstract MP73-05), The Journal of Urology (2023)
Magnetic Resonance Imaging-Guided TransurethralUltrasound Ablation of Prostate Cancer: A Systematic Review
Dora et al, Journal of Endourology (2022)

Clinical Publications

106734B

Quick Links

Careers & Training

Head Office

Profound Medical Corp.,
2400 Skymark Avenue,
Unit #6, Mississauga, ON L4W 5K5, Canada

T: 647.476.1350
F: 647.847.3739
info@profoundmedical.com